Muscle Pharm Corporation. Stock OTC Bulletin Board
Equities
US6273351022
Investment Holding Companies
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2020 | 64.44M 88.18M | Sales 2021 | 50.04M 68.48M | Capitalization | 13.35M 18.28M |
---|---|---|---|---|---|
Net income 2020 | 3M 4.11M | Net income 2021 | -12M -16.42M | EV / Sales 2020 | 0.27 x |
Net Debt 2020 | 10.43M 14.28M | Net Debt 2021 | 15.93M 21.8M | EV / Sales 2021 | 0.59 x |
P/E ratio 2020 |
2.55
x | P/E ratio 2021 |
-1.03
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 88.94% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 23-02-12 |
Eric Chin
DFI | Director of Finance/CFO | 44 | 22-06-16 |
Chairman | 53 | 15-08-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Hillman
CEO | Chief Executive Officer | - | 23-02-12 |
Michael Heller
BRD | Director/Board Member | 48 | 21-01-18 |
Chairman | 53 | 15-08-25 |
1st Jan change | Capi. | |
---|---|---|
+107.43% | 7.01B | |
+2.71% | 987M | |
+51.92% | 976M | |
+2.59% | 669M | |
-.--% | 600M | |
-2.15% | 593M | |
+10.28% | 536M | |
-.--% | 500M | |
+6.56% | 470M |